PL369372A1 - Postać polimorficzna rymonabantu, sposób jej wytwarzania i zawierające je środki farmaceutyczne - Google Patents

Postać polimorficzna rymonabantu, sposób jej wytwarzania i zawierające je środki farmaceutyczne

Info

Publication number: PL369372A1
Authority: PL; Poland
Prior art keywords: rimonabant; preparation; pharmaceutical compositions; compositions containing; containing same
Prior art date: 2001-11-08

Application number

PL02369372A

Other languages

English (en)

Inventor

Alain Alcade

Gilles Anne-Archard

Corinne Gavory

Olivier Monnier

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-08

Filing date

2002-11-04

Publication date

2005-04-18

2002-11-04 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2005-04-18 Publication of PL369372A1 publication Critical patent/PL369372A1/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL02369372A 2001-11-08 2002-11-04 Postać polimorficzna rymonabantu, sposób jej wytwarzania i zawierające je środki farmaceutyczne PL369372A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0114579A FR2831883B1 (fr)	2001-11-08	2001-11-08	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

Publications (1)

Publication Number	Publication Date
PL369372A1 true PL369372A1 (pl)	2005-04-18

Family

ID=8869285

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02369372A PL369372A1 (pl)	2001-11-08	2002-11-04	Postać polimorficzna rymonabantu, sposób jej wytwarzania i zawierające je środki farmaceutyczne

Country Status (33)

Country	Link
US (2)	US20050043356A1 (pl)
EP (1)	EP1446384A1 (pl)
JP (2)	JP4181994B2 (pl)
KR (2)	KR20090089485A (pl)
CN (1)	CN100412063C (pl)
AP (1)	AP1830A (pl)
AR (1)	AR037253A1 (pl)
AU (1)	AU2002350869B2 (pl)
BR (1)	BR0213931A (pl)
CA (1)	CA2464145A1 (pl)
CO (1)	CO5580827A2 (pl)
CR (1)	CR7333A (pl)
EA (1)	EA006771B1 (pl)
EC (1)	ECSP045088A (pl)
FR (1)	FR2831883B1 (pl)
GE (1)	GEP20063894B (pl)
HR (1)	HRP20040403A2 (pl)
HU (1)	HUP0402043A3 (pl)
IL (2)	IL161533A0 (pl)
IS (1)	IS7226A (pl)
MA (1)	MA27080A1 (pl)
ME (1)	MEP21908A (pl)
MX (1)	MXPA04004394A (pl)
NO (1)	NO326648B1 (pl)
NZ (1)	NZ532369A (pl)
OA (1)	OA12721A (pl)
PL (1)	PL369372A1 (pl)
RS (1)	RS36904A (pl)
TN (1)	TNSN04079A1 (pl)
TW (1)	TW200302824A (pl)
UA (1)	UA76776C2 (pl)
WO (1)	WO2003040105A1 (pl)
ZA (1)	ZA200402999B (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2831883B1 (fr) *	2001-11-08	2004-07-23	Sanofi Synthelabo	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
CA2487849A1 (en)	2002-07-18	2004-01-29	Cytos Biotechnology Ag	Hapten-carrier conjugates comprising virus like particles and uses thereof
FR2861992B1 (fr) *	2003-11-10	2007-07-20	Sanofi Synthelabo	Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
EP2308840A1 (en)	2005-06-30	2011-04-13	Prosidion Limited	GPCR agonists
EP1816125A1 (en) *	2006-02-02	2007-08-08	Ranbaxy Laboratories, Ltd.	Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof
FR2897060B1 (fr) *	2006-02-08	2008-07-25	Sanofi Aventis Sa	Le monohydrate de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
WO2008038143A2 (en) *	2006-06-22	2008-04-03	Medichem, S.A.	Novel solid forms of rimonabant and synthetic processes for their preparation
WO2008044153A2 (en) *	2006-08-29	2008-04-17	Medichem, S.A.	Improved method for synthesizing rimonabant
WO2008026219A2 (en) *	2006-09-01	2008-03-06	Hetero Drugs Limited	Novel polymorphs of rimonabant
WO2008032330A2 (en) *	2006-09-11	2008-03-20	Hetero Drugs Limited	Improved process for rimonabant
WO2008035023A1 (en) *	2006-09-19	2008-03-27	Cipla Limited	Polymorphs of rimonabant
WO2008056377A2 (en) *	2006-11-06	2008-05-15	Cadila Healthcare Limited	Polymorphic forms of rimonabant
WO2008064615A2 (en) *	2006-12-01	2008-06-05	Zentiva, A.S.	Crystalline and amorphous forms of rimonabant and processes for obtaining them
WO2008075013A1 (en) *	2006-12-18	2008-06-26	7Tm Pharma A/S	Modulators of cannabinoid receptor
AR064736A1 (es)	2007-01-04	2009-04-22	Prosidion Ltd	Agonistas de gpcr
US20100048625A1 (en)	2007-01-04	2010-02-25	Matthew Colin Thor Fyfe	Piperidine gpcr agonists
PT2114933E (pt)	2007-01-04	2011-12-20	Prosidion Ltd	Agonistas do gpcr de piperidina
GB0700122D0 (en)	2007-01-04	2007-02-14	Prosidion Ltd	GPCR agonists
PE20081659A1 (es)	2007-01-04	2008-10-24	Prosidion Ltd	Agonistas de gpcr
EP1944297A1 (en) *	2007-01-09	2008-07-16	Miklós Vértessy	Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof
WO2008088900A2 (en) *	2007-01-18	2008-07-24	Teva Pharmaceutical Industries Ltd.	Polymorphic forms of rimonabant base and processes for preparation thereof
EP1953144A1 (en)	2007-01-30	2008-08-06	Sandoz AG	Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide
FR2919865A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de dmso de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919864A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de 1,4-dioxane de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919867A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de 2-methoxyethanol de rimonabant et son procede de preparation
FR2919862A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de 3-methylbutan-1-ol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
FR2919863A1 (fr) *	2007-08-06	2009-02-13	Sanofi Aventis Sa	Le solvate de n-methylpyrrolidone de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
GB0720390D0 (en)	2007-10-18	2007-11-28	Prosidion Ltd	G-Protein coupled receptor agonists
GB0720389D0 (en)	2007-10-18	2008-11-12	Prosidion Ltd	G-Protein Coupled Receptor Agonists
WO2009153804A1 (en) *	2008-06-16	2009-12-23	Cadila Healthcare Limited	Process for preparing form i of rimonabant
WO2010079241A1 (es)	2009-01-12	2010-07-15	Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion	Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
FR3008620A1 (fr) *	2013-07-22	2015-01-23	Sanofi Sa	Formulation de comprime d'un inhibiteur de phosphatidylinositol 3-kinase
JPWO2021075494A1 (pl) *	2019-10-16	2021-04-22

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2713225B1 (fr) *	1993-12-02	1996-03-01	Sanofi Sa	N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US7109245B2 (en) *	2001-08-15	2006-09-19	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Vasoconstrictor cannabinoid analogs
FR2831883B1 (fr) *	2001-11-08	2004-07-23	Sanofi Synthelabo	Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant

2001
- 2001-11-08 FR FR0114579A patent/FR2831883B1/fr not_active Expired - Fee Related
2002
- 2002-04-11 UA UA20040402974A patent/UA76776C2/uk unknown
- 2002-11-04 GE GE5606A patent/GEP20063894B/en unknown
- 2002-11-04 EA EA200400491A patent/EA006771B1/ru not_active IP Right Cessation
- 2002-11-04 BR BR0213931-6A patent/BR0213931A/pt not_active IP Right Cessation
- 2002-11-04 HU HU0402043A patent/HUP0402043A3/hu unknown
- 2002-11-04 CA CA002464145A patent/CA2464145A1/en not_active Abandoned
- 2002-11-04 KR KR1020097016373A patent/KR20090089485A/ko not_active Application Discontinuation
- 2002-11-04 US US10/494,211 patent/US20050043356A1/en not_active Abandoned
- 2002-11-04 OA OA1200400131A patent/OA12721A/fr unknown
- 2002-11-04 WO PCT/FR2002/003765 patent/WO2003040105A1/fr active Application Filing
- 2002-11-04 JP JP2003542151A patent/JP4181994B2/ja not_active Expired - Fee Related
- 2002-11-04 AU AU2002350869A patent/AU2002350869B2/en not_active Ceased
- 2002-11-04 EP EP02785580A patent/EP1446384A1/fr not_active Withdrawn
- 2002-11-04 RS YU36904A patent/RS36904A/sr unknown
- 2002-11-04 KR KR1020047006969A patent/KR20050043774A/ko not_active Application Discontinuation
- 2002-11-04 NZ NZ532369A patent/NZ532369A/en not_active IP Right Cessation
- 2002-11-04 PL PL02369372A patent/PL369372A1/pl not_active Application Discontinuation
- 2002-11-04 MX MXPA04004394A patent/MXPA04004394A/es unknown
- 2002-11-04 CN CNB028219686A patent/CN100412063C/zh not_active Expired - Fee Related
- 2002-11-04 IL IL16153302A patent/IL161533A0/xx unknown
- 2002-11-04 ME MEP-219/08A patent/MEP21908A/xx unknown
- 2002-11-04 AP APAP/P/2004/003024A patent/AP1830A/en active
- 2002-11-06 AR ARP020104228A patent/AR037253A1/es unknown
- 2002-11-07 TW TW091132763A patent/TW200302824A/zh unknown
2004
- 2004-04-19 IS IS7226A patent/IS7226A/is unknown
- 2004-04-20 IL IL161533A patent/IL161533A/en not_active IP Right Cessation
- 2004-04-20 ZA ZA200402999A patent/ZA200402999B/en unknown
- 2004-04-27 EC EC2004005088A patent/ECSP045088A/es unknown
- 2004-04-28 MA MA27659A patent/MA27080A1/fr unknown
- 2004-05-04 CO CO04040840A patent/CO5580827A2/es not_active Application Discontinuation
- 2004-05-04 CR CR7333A patent/CR7333A/es unknown
- 2004-05-06 HR HR20040403A patent/HRP20040403A2/hr not_active Application Discontinuation
- 2004-05-07 TN TNP2004000079A patent/TNSN04079A1/fr unknown
- 2004-05-07 NO NO20041879A patent/NO326648B1/no not_active IP Right Cessation
2008
- 2008-07-11 JP JP2008181474A patent/JP4931874B2/ja not_active Expired - Fee Related
- 2008-10-28 US US12/259,701 patent/US20100190827A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MXPA04004394A (es)	2004-08-11
ECSP045088A (es)	2004-06-28
IS7226A (is)	2004-04-19
AR037253A1 (es)	2004-11-03
IL161533A (en)	2010-05-31
US20100190827A1 (en)	2010-07-29
ZA200402999B (en)	2005-04-20
NO326648B1 (no)	2009-01-26
UA76776C2 (uk)	2006-09-15
JP2009035547A (ja)	2009-02-19
AP2004003024A0 (en)	2004-06-30
JP4181994B2 (ja)	2008-11-19
NO20041879L (no)	2004-06-08
KR20090089485A (ko)	2009-08-21
CN100412063C (zh)	2008-08-20
HUP0402043A2 (hu)	2005-01-28
HRP20040403A2 (en)	2004-08-31
JP4931874B2 (ja)	2012-05-16
FR2831883B1 (fr)	2004-07-23
CA2464145A1 (en)	2003-05-15
AU2002350869B2 (en)	2007-07-26
EA200400491A1 (ru)	2004-12-30
CO5580827A2 (es)	2005-11-30
TNSN04079A1 (fr)	2006-06-01
CN1582278A (zh)	2005-02-16
RS36904A (en)	2006-10-27
MEP21908A (en)	2010-06-10
CR7333A (es)	2008-09-23
US20050043356A1 (en)	2005-02-24
EP1446384A1 (fr)	2004-08-18
KR20050043774A (ko)	2005-05-11
NZ532369A (en)	2005-10-28
IL161533A0 (en)	2004-09-27
NO20041879D0 (no)	2004-05-07
HUP0402043A3 (en)	2009-07-28
AP1830A (en)	2008-02-22
BR0213931A (pt)	2004-09-08
MA27080A1 (fr)	2004-12-20
OA12721A (fr)	2006-06-27
TW200302824A (en)	2003-08-16
FR2831883A1 (fr)	2003-05-09
GEP20063894B (en)	2006-08-10
EA006771B1 (ru)	2006-04-28
WO2003040105A1 (fr)	2003-05-15
JP2005508383A (ja)	2005-03-31

Similar Documents

Publication	Publication Date	Title
HUP0402043A3 (en)	2009-07-28	Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same
AU2002350869A1 (en)	2003-07-24	Polymorphous form of rimonabant, preperation method and pharmaceutical compositions containing same
HUP0401537A3 (en)	2005-06-28	Thiohydantoins, process for their preparation, pharmaceutical compositions containing them and use thereof for preparation of pharmaceutical compositions
HUP0402264A3 (en)	2010-03-29	Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HUP0402225A3 (en)	2006-01-30	Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0402063A3 (en)	2008-03-28	Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
HU0103063D0 (en)	2001-10-28	New 2h-pyridazin-3-one derivatives, process for their preparation and pharmaceutical compositions containing them
HU228253B1 (en)	2013-02-28	Substituted cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
HU229604B1 (en)	2014-02-28	6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0401250A3 (en)	2008-04-28	Medical aerosol compositions and process for their preparation
HUP0401747A3 (en)	2005-06-28	Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
PL356911A1 (pl)	2004-07-12	Skondensowane związki azolowe i ich stosowanie jako środki hipoglikemiczne
HUP0401018A3 (en)	2007-05-29	2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0401082A3 (en)	2011-07-28	Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
IL158660A0 (en)	2004-05-12	Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
PL360090A1 (pl)	2004-09-06	Nowe związki aminotriazolonu, proces ich otrzymywania oraz zawierające je kompozycje farmaceutyczne
AU2002306687A1 (en)	2002-09-24	Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
SI1245565T1 (en)	2003-12-31	Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them
PL368237A1 (pl)	2005-03-21	Nowe związki hydroksyalkiloindolokarbazolowe, sposób ich wytwarzania oraz zawierające je kompozycjefarmaceutyczne
SI1241169T1 (en)	2003-12-31	Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
AU2207902A (en)	2002-06-11	Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
HUP0401161A3 (en)	2009-04-28	Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride, process for their preparation and pharmaceutical compositions containing the crystalline forms
HUP0304065A2 (hu)	2004-04-28	Új 5-tio-béta-D-xilopiranozid-származékok, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati kompozíciók és alkalmazásuk
HUP0401038A3 (en)	2011-08-29	Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them
SI1266887T1 (sl)	2005-12-31	Derivati indenoindolona, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo

Legal Events

Date	Code	Title	Description
2011-05-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)